Susquehanna Fundamental Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-96,288	Closed	-$722K	–	748
2025 Q1	$722K	Buy	96,288 +7,434	+8%	+$55.8K	0.01%	763
2024 Q4	$668K	Buy	+88,854	New	+$668K	0.01%	803
2024 Q2	$186K	Sell	30,176 -34,189	-53%	-$211K	﹤0.01%	854
2024 Q1	$327K	Buy	+64,365	New	+$327K	0.02%	538